Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:13
  • preuzimanja u poslednjih 30 dana:7
članak: 1 od 8  
Back povratak na rezultate
Acta Facultatis Medicae Naissensis
2019, vol. 36, br. 2, str. 91-101
jezik rada: engleski
vrsta rada: pregledni članak
objavljeno: 09/09/2019
doi: 10.5937/afmnai1902091S
Creative Commons License 4.0
Anksiozni poremećaji - trenutno stanje stvari? Preporučena medikamentozna terapija i perspektive
aUniverzitet u Nišu, Medicinski fakultet
bUniverzitet u Nišu, Medicinski fakultet + Klinički centar Niš, Klinika za zaštitu mentalnog zdravlja
cUniverzitet u Nišu, Medicinski fakultet + Univerzitet u Nišu, Prirodno-matematički fakultet, Odsek Hemija
dUniverzitet u Nišu, Medicinski fakultet, Katedra Fiziologija
eUniverzitet u Nišu, Prirodno-matematički fakultet, Odsek Hemija

e-adresa: nikola.st90@yahoo.com

Projekat

Kombinatorne biblioteke heterogenih katalizatora, prirodnih proizvoda, modifikovanih prirodnih proizvoda i njihovih analoga: put ka novim biološki aktivnim agensima (MPNTR - 172061)

Sažetak

Učestalost anksioznih poremećaja je značajno povećana poslednjih decenija, a posebno među mlađim generacijama. Ovaj pregledni članak je usmeren da objasni razliku između straha i anksioznosti, a baviće se i poremećajima koji mogu da imitiraju anksioznost ili da dovedu do nje, kao i neurofizioloških mehanizmima koji su uključeni u procesuiranje anksioznosti. Značajan deo ovog članka je posvećen trenutnim preporukama za medikamentoznu terapiju koja predstavlja osnovu lečenja anksioznih poremećaja. Takođe, posvetiće se pažnja i mogućoj primeni prirodnih biljnih lekova u terapiji različitih anksioznih poremećaja.

Ključne reči

anksioznost; strah; moždane stukture; farmakoterapija; prirodni biljni lekovi

Reference

Ahissar, E., Oram, T. (2015) Thalamic Relay or Cortico-Thalamic Processing? Old Question, New Answers. Cerebral Cortex, 25(4): 845-848
Baldwin, D.S. (2008) Room for improvement in the pharmacological treatment of anxiety disorders. Current Pharmaceutical Design, 14(33): 3482-3491
Baldwin, D.S., Brandish, E.K. (2014) Pharmacological Treatment of Anxiety Disorders. u: Emmelkamp P, Ehring T. [ur.] The Wiley Handbook of Anxiety Disorders, John Wiley & Sons, Ltd, First Edition
Bandelow, B., Michaelis, S., Wedekind, D. (2017) Treatment of anxiety disorders. Dialogues Clin Neurosci, 19: 93-106
Bandelow, B. (2015) Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci, 17: 327-362
Barlow, D.H. (1988) Anxiety and its disorders: The nature and treatment of anxiety and panic. New York: Guilford Press
Barlow, D.H. (2000) Unraveling the mysteries of anxiety and its disorders from the perspective of emotion theory. American Psychologist, 55(11): 1247-1263
Blaustein, J.D. (2006) Handbook of Neurochemistry and Molecular Neurobiology: Behavioral Neurochemistry, Neuroendocrinology and Molecular Neurobiology. Springer
Bourin, M. (2015) Animal models for screening anxiolyticlike drugs: A perspective. Dialogues Clin Neurosci, 17: 295-303
Bystritsky, A., Khalsa, S.S., Cameron, M.E., Schiffman, J. (2013) Current diagnosis and treatment of anxiety disorders. P T, 38: 30-57
Craig, K.J., Brown, K.J., Baum, A. (1995) Environmental factors in the etiology of anxiety. u: Bloom FE, Kupfer DJ [ur.] Psychopharmacology: The Fourth Generation of Progress, New York: Raven Press, 1325-39
Duval, E.R., Javanbakht, A., Liberzon, I. (2015) Neural circuits in anxiety and stress disorders: A focused review. Ther Clin Risk Manag, 11: 115-141
Emond, M., Schwartz, G.J., Moran, T.H. (2001) Meal-related stimuli differentially induce c-Fos activation in the nucleus of the solitary tract. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 280(5): R1315-R1321
Garcia-Rill, E., Kezunovic, N., Hyde, J., Simon, C., Beck, P., Urbano, F.J. (2013) Coherence and frequency in the reticular activating system (RAS). Sleep Medicine Reviews, 17(3): 227-238
Gelenberg, A.J. (2000) Psychiatric and somatic markers of anxiety: Identification and pharmacologic treatment. Prim Care Companion J Clin Psychiatry, 2: 49-54
Goddard, A.W., Brouette, T., Almai, A., Jetty, P., Woods, S.W., Charney, D. (2001) Early coadministration of clonazepam with sertraline for panic disorder. Archives of General Psychiatry, 58(7): 681-681
Hanson, C., Modiba, W. (2017) Overview and management of anxiety disorders. S Afr Pharm J, 84: 43-50
Katzung, B., Masters, S.B., Trevor, A.J. (2012) Basic and Clinical Pharmacology. McGraw-Hill Lange, 12 th Ed
Lee, S., Shin, H.S. (2016) The role of mediodorsal thalamic nucleus in fear extinction. Journal of Analytical Science and Technology, 7: 13
Mayer, E.A. (2011) Gut feelings: The emerging biology of gut-brain communication. Nature Reviews Neuroscience, 12(8): 453-466
McCall, J.G., Siuda, E.R., Bhatti, D.L., Lawson, L.A., McElligott, Z.A., Stuber, G.D., Bruchas, M.R. (2017) Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior. eLife, 6: e18247
Morris, L.W., Davis, M.A., Hutchings, C.H. (1981) Cognitive and emotional components of anxiety: Literature review and a revised worry-emotionality scale. Journal of Educational Psychology, 73(4): 541-555
Muscatello, M.R., Spina, E., Bandelow, B., Baldwin, D.S. (2012) Clinically relevant drug interactions in anxiety disorders. Human Psychopharmacology: Clinical and Experimental, 27(3): 239-253
Nešić, M. (2005) Pshichoneuroendocrino-immunology of stress. Niš, Serbia: Faculty of Medicine, The book is written in Serbian
Nutt, D.J. (2005) Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectrums, 10(1): 49-56
Remes, O., Brayne, C., van der Linde, R., Lafortune, L. (2016) A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain and Behavior, 6(7): e00497-e00497
Sarris, J. (2018) Herbal medicines in the treatment of psychiatric disorders: 10-year updated review. Phytotherapy Research, 32(7): 1147-1162
Shin, L.M., Liberzon, I. (2010) The Neurocircuitry of Fear, Stress, and Anxiety Disorders. Neuropsychopharmacology, 35(1): 169-191
Simpson, H.B., Neria, Y., Lewis-Fernandez, R., Schneier, F. (2010) Anxiety disorders: Theory, research and clinical perspectives. Cambridge: Cambridge University Press, 1st ed
Starčević, V. (2005) Bez straha, o strahu, panici i fobiji. Beograd: Mladost Biro, The book is written in Serbian
Steimer, T. (2002) The biology of fear- and anxiety-related behaviors. Dialogues Clin Neurosci, 4(3): 231-49
Stern, T., Fricchione, G., Rosenbaum, J. (2010) Massachusetts General Hospital Handbook of General Hospital Psychiatry. Philadelphia: Saunders Elsevier, 6 th Edition, 133-52
Stojanović, N.M., Samardžić, L., Randjelović, P.J., Radulović, N.S. (2017) Prevalence of self-medication practice with herbal products among non-psychotic psychiatric patients from southeastern Serbia: A cross-sectional study. Saudi Pharmaceutical Journal, 25(6): 884-890
Thibaut, F. (2017) Anxiety disorders: A review of current literature. Dialogues Clin Neuroscience, 87-95
Yeung, S.K., Hernandez, M., Mao, J.J., Haviland, I., Gubili, J. (2018) Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance. Phytotherapy Research, 32: 1-27